Jove
Visualize
Contact Us

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

85.5K
Overview
85.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Multiple Allele Traits01:49

Multiple Allele Traits

38.5K
The Concept of Multiple Allelism
38.5K
What is the Immune System?01:38

What is the Immune System?

141.0K
Overview
141.0K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.3K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting erythroid cell-derived asparagine inhibits alloimmunization in sickle cell disease.

Blood advances·2026
Same author

Effect of sildenafil on platelet activation and mediators of vascular remodelling during LVAD support.

ESC heart failure·2026
Same author

Warm autoimmune haemolytic anaemia: Clinical considerations.

British journal of haematology·2026
Same author

Heme-induced activation of the TLR3/TRIF-IFN-I-CCL2 pathway contributes to kidney injury in sickle cell disease.

Blood·2026
Same author

Safety and efficacy of combined heparin/citrate anticoagulation for cell therapy collections in healthy adult allogeneic donors.

Transfusion·2025
Same author

HCAR2 the rescue: sensing heme, steering inflammation.

Blood advances·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 11, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.0K

Immunoregulatory networks in sickle cell alloimmunization.

Karina Yazdanbakhsh1

  • 1Laboratory of Complement Biology, New York Blood Center, New York, NY.

Hematology. American Society of Hematology. Education Program
|December 4, 2016
PubMed
Summary

Sickle cell disease patients receiving red blood cell transfusions often develop alloimmunization due to immune system differences. Research is identifying cellular immune response variations to predict and prevent these antibody responses.

More Related Videos

Generation of Human Alloantigen-specific T Cells from Peripheral Blood
09:47

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

Published on: November 21, 2014

13.6K
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

14.0K

Related Experiment Videos

Last Updated: Mar 11, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.0K
Generation of Human Alloantigen-specific T Cells from Peripheral Blood
09:47

Generation of Human Alloantigen-specific T Cells from Peripheral Blood

Published on: November 21, 2014

13.6K
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
09:04

Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

Published on: April 19, 2017

14.0K

Area of Science:

  • Immunology
  • Hematology
  • Genetics

Background:

  • Red blood cell (RBC) transfusions are vital for managing sickle cell disease (SCD).
  • Alloimmunization, the development of antibodies against foreign RBC antigens, is a significant complication of transfusions in SCD patients.
  • Higher alloimmunization rates in SCD are linked to donor-recipient demographic disparities and transfusion frequency.

Purpose of the Study:

  • To investigate the cellular immune response differences between alloimmunized and non-alloimmunized SCD patients.
  • To identify potential biomarkers and therapeutic targets for preventing or mitigating alloantibody responses in SCD.

Main Methods:

  • Characterization of cellular immune responses, focusing on T helper cell subsets (T regulatory, TH1, TH17, follicular helper T cells).
  • Analysis of innate immune cell responses to cell-free heme in SCD patients.
  • Comparison of immune profiles between alloimmunized and non-alloimmunized SCD patient cohorts.

Main Results:

  • Alloimmunized SCD patients exhibit altered CD4+ T helper cell responses, impacting immunoglobulin G production.
  • Heightened innate immune responses to cell-free heme and a proinflammatory T cell profile were observed in SCD antibody responders.
  • The chronic hemolytic state in SCD may compromise innate immune cells' ability to prevent alloimmunization.

Conclusions:

  • Differences in cellular immune pathways between alloimmunized and non-alloimmunized SCD patients are being elucidated.
  • Identifying these molecular pathways could lead to biomarkers for alloimmunization.
  • This research may pave the way for targeted therapies to prevent or reduce alloantibody formation in susceptible SCD patients.